ArticleTransplantation and cellular therapy2023

Dawn of Hope for Improved Access to BCMA Therapy: Chimeric Antigen Receptor T Cell and Bispecific Products.

Nausheen Ahmed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.